, Volume 52, Issue 7, pp 633–644

Intracranial stenting in atherosclerotic disease—recent results and challenges to face

  • Wiebke Kurre
  • René Chapot
  • Richard du Mesnil de Rochemont
  • Joachim Berkefeld
Topic Article


Intracranial stenting is increasingly used as an add-on to medical therapy despite the fact that the overall clinical benefit remains a matter of debate, since we lack results of randomized trials. Decision making on interventional treatment is made on the grounds of the anticipated risk of stroke with antiplatelet medication on one hand and on the experience with stent treatment based on data from case series and registries on the other hand. This review will summarize the current knowledge on both topics serving as the fundament of patient selection for intracranial stenting. A second objective is to highlight some specific problems that are encountered when treating patients interventionally. Procedure-related complication rates and rates of in stent stenoses are still too high to be confident that endovascular treatment is superior to medical therapy of symptomatic stenoses. Optimization of patient selection criteria, stent technology, and periprocedural management are necessary to become undoubtedly competitive with antiplatelet therapy. With the current stage of development, interventional treatment of intracranial stenoses should be confined to specialized centers with a high expertise in neurovascular procedures.


Review Intracranial stenosis Intracranial stent Intracranial angioplasty 


  1. 1.
    Weimar C, Goertler M, Harms L, Diener H-C (2006) Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol 63:1287–1291CrossRefPubMedGoogle Scholar
  2. 2.
    Sacco RL, Kargman DE, Gu Q, Zamanillo MC (1995) Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 26:14–20PubMedGoogle Scholar
  3. 3.
    Wong KS, Huang YN, Gao S, Lam WWM, Chan YL, Kay R (1998) Intracranial stenosis in Chinese patients with acute stroke. Neurology 50:812–813PubMedGoogle Scholar
  4. 4.
    Gorelick PB, Wong KS, Bae HJ, Pandey DK (2008) Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 39:2396–2399CrossRefPubMedGoogle Scholar
  5. 5.
    Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305–1316CrossRefPubMedGoogle Scholar
  6. 6.
    Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ (2006) Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555–563CrossRefPubMedGoogle Scholar
  7. 7.
    The Warfarin-Aspirin Symtomatic Intracranial Disease (WASID) Trial Investigators (2003) Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 22:106–117CrossRefGoogle Scholar
  8. 8.
    Famakin BM, Chimowitz MI, Lynn MJ, Stern BJ, George MG, for the WASID Trial Investigators (2009) Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 40:1999–2003CrossRefPubMedGoogle Scholar
  9. 9.
    Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F (2006) Prospective study of symptomatic atherothrombotic intracranial stenoses—the GESICA Study. Neurology 66:1187–1191CrossRefPubMedGoogle Scholar
  10. 10.
    Williams JE, Chimowitz MI, Cotsonis GA, Lynn MJ, Waddy SP (2007) Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke 38:2055–2062CrossRefPubMedGoogle Scholar
  11. 11.
    Turan TN, Maidan L, Cotsonis G, Lynn MJ, Romano JG, Levine SR, Chimowitz MI (2009) Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke 40:505–509CrossRefPubMedGoogle Scholar
  12. 12.
    Thijs VN, Albers GW (2000) Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 55:490–498PubMedGoogle Scholar
  13. 13.
    Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, Frankel M, Chimowitz MI, for the WASID Study Group (2007) Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 69:2063–2068CrossRefPubMedGoogle Scholar
  14. 14.
    Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M, for the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators (2007) Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 115:2969–2975CrossRefPubMedGoogle Scholar
  15. 15.
    Arenillas JF, Molina CA, Montaner J, Abilleira S, González-Sánchez MA, Álvarez-Sabin J (2001) Progression and clinical recurrence of symptomatic middle cerebral artery stenosis. A Long-term Follow-up Transcranial Doppler Ultrasound Study. Stroke 32:2898–2904CrossRefPubMedGoogle Scholar
  16. 16.
    Arenillas JF, Álvarez-Sabín J, Molina CA, Chacón P, Fernández-Cadenas I, Ribó M, Delgado P, Rubiera M, Penalba A, Rovira A, Montaner J (2008) Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke 39:1456–1463CrossRefPubMedGoogle Scholar
  17. 17.
    Arenillas JF, Álvarez-Sabin J, Molina CA, Chacón P, Montaner J, Rovira Á, Ibarra B, Quintana M (2003) C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34:2463–2470CrossRefPubMedGoogle Scholar
  18. 18.
    Takahashi W, Ohnuki T, Ide M, Takagi S, Shinohara Y (2006) Stroke risk of asymptomatic intra- and extracranial large-artery disease in apparently healthy adults. Cerebrovasc Dis 22:263–270CrossRefPubMedGoogle Scholar
  19. 19.
    Kern R, Steinke W, Daffertshofer M, Prager R, Hennerici M (2005) Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 65:859–864CrossRefPubMedGoogle Scholar
  20. 20.
    Kremer C, Schaettin T, Georgiadis D, Baumgartner RW (2004) Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Psychiatry 75:1300–1303CrossRefGoogle Scholar
  21. 21.
    Nahab F, Cotsonis G, Lynn M, Feldmann E, Chaturvedi S, Hemphill JC, Zweifler R, Johnston K, Bonovich D, Kasner S, Chimowitz M (2008) Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke 39:1039–1041CrossRefPubMedGoogle Scholar
  22. 22.
    Famakin BM, Chimowitz MI, Lynn MJ, Stern BJ, George MG, for the WASID Trial Invesitgators (2009) Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 40:1999–2003CrossRefPubMedGoogle Scholar
  23. 23.
    Cruz-Flores S, Diamond AL (2006) Angioplasty for intracranial artery stenosis Cochrane database. Syst Rev 3:CD004133Google Scholar
  24. 24.
    Gröschel K, Schnaudigel S, Pilgram SM, Wasser K, Kastrup A (2009) A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 40:e340–e347CrossRefPubMedGoogle Scholar
  25. 25.
    Nahab F, Lynn MJ, Kasner SE, Alexander MJ, Klucznik R, Zaidat OO, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Chimowitz MI, for the NIH Multicenter Wingspan Intracranial Stent Registry Study Group (2009) Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 72:2014–2019CrossRefPubMedGoogle Scholar
  26. 26.
    Kurre W, Berkefeld J, Brassel F, Brüning R, Eckert B, Kamek S, Klein GE, Knauth M, Liebig T, Maskova J, Mucha D, Neumann-Haefelin T, Pilgram-Pastor S, Sitzer M, Sonnberger M, Tietke M, Trenkler J, Turowski B, for the INTRASTENT Study Group (2010) In hospital complication rates after stent treatment of 388 intracranial stenoses—results from the INTRASTENT multicentric registry. Stroke 41:494–498PubMedGoogle Scholar
  27. 27.
    Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wan QH, Ma N (2007) Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenoses. Neurology 68:420–426CrossRefPubMedGoogle Scholar
  28. 28.
    Ogasawara K, Sakai N, Kuroiwa T, Hosoda K, Iihara K, Toyoda K, Sakai C, Nagata I, Ogawa A, Japanese Society For Treatment AT Neck In Cerebrovascular Disease Study Group (2007) Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. J Neurosurg 107:1130–1136CrossRefPubMedGoogle Scholar
  29. 29.
    Moulakakis KG, Mylonas SN, Sfyroeras GS, Andrikopoulos V (2009) Hyperperfusion syndrome after carotid revascularization. J Vasc Surg 49:1060–1068CrossRefPubMedGoogle Scholar
  30. 30.
    Medel R, Crowley RW, Dumont A (2009) Hyperperfusion syndrome following endovascular cerebral revascularization. Neurosurg Focus 26:E4CrossRefPubMedGoogle Scholar
  31. 31.
    Meyers PM, Higashida R, Phatouros C, Adel MA, Lempert TE, Dowd CF, van Halbach VMD (2000) Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery 47:335–345CrossRefPubMedGoogle Scholar
  32. 32.
    Rezende MT, Spelle L, Mounayer C, Piotin M, Abud DG, Moret J (2006) Hyperperfusion syndrome after stenting for intracranial vertebral stenosis. Stroke 37:e12–e14CrossRefPubMedGoogle Scholar
  33. 33.
    Liu AY, Do HM, Albers GW, Lopez JR, Steinberg GK, Marks MP (2001) Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. Am J Neuroradiol 22:1597–1601PubMedGoogle Scholar
  34. 34.
    Terada T, Tsuura M, Matsumoto H, Masuo O, Tsumoto T, Yamaga H, Ohura Y, Itakura T (2006) Hemorrhagic complications after endovascular therapy for atherosclerotic intracranial arterial stenosis. Neurosurgery 59:310–318CrossRefPubMedGoogle Scholar
  35. 35.
    van Mool WNKA, Rennenberg RJMW, Schurink GW, van Oostenbrugge RJ, Mess WH, Hofmann PAM, de Leeuw PW (2005) Cerebral hyperperfusion syndrome. Lancet Neurol 4:877–888CrossRefGoogle Scholar
  36. 36.
    Abou-Chebl A, Yadav JS, Reginelli JP, Bajzer C, Bhatt D, Krieger DW (2004) Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting. J Am Coll Cardiol 43:1596–1601CrossRefPubMedGoogle Scholar
  37. 37.
    Kaku Y, Yoshimura SI, Kokuzawa J (2004) Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. Am J Neuroradiol 25:1403–1408PubMedGoogle Scholar
  38. 38.
    Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS (2007) Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting catheter. Cardiovasc Interv 69:690–696CrossRefGoogle Scholar
  39. 39.
    Yoshimura S, Kitajima H, Enomoto Y, Yamada K, Iwama T (2009) Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion. Neurosurgery 64(Suppl):122–128PubMedGoogle Scholar
  40. 40.
    Levy EI, Hanel RA, Boulos AS, Bendok BR, Kim SH, Gibbons KJ, Qureshi AI, Guterman LR, Hopkins LN (2003) Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg 99:653–660CrossRefPubMedGoogle Scholar
  41. 41.
    Poerner TC, Kralev S, Voelker W, Sueselbeck T, Latsch A, Pfleger S, Schumacher B, Borggrefe M, Haase KK (2002) Natural history of small and medium-sized side branches after coronary stent implantation. Am Heart J 143:627–635CrossRefPubMedGoogle Scholar
  42. 42.
    Marinkovic S, Milisavljevic M, Gibo H, Malicovic A, Djulejic V (2004) Microsurgical anatomy of the perforating branches of the vertebral artery. Surg Neurol 61:190–197CrossRefPubMedGoogle Scholar
  43. 43.
    Marinkovic S, Gibo H (1993) The surgical anatomy of the perforating branches of the basilar artery. Neurosurgery 33:80–87CrossRefPubMedGoogle Scholar
  44. 44.
    Marinkovic S, Gibo H, Milisavljevic M, Cetkovic M (2001) Anatomic and clinical correlations of the lenticulostriate arteries. Clin Anat 14:190–195CrossRefPubMedGoogle Scholar
  45. 45.
    Lopes DK, Ringer AJ, Boulos AS, Qreshi AI, Lieber BB, Guterman LR, Hopkins LN (2003) Fate of branch arteries after intracranial stenting. Neurosurgery 52(6):1275–1279CrossRefPubMedGoogle Scholar
  46. 46.
    Masuo O, Terada T, Walker G, Tsuura M, Matsumoto H, Tohya K, Kimura M, Nakai K, Itakura T (2002) Study of the patency of small arterial branches after stent placement with and experimental in vivo model. Am J Neuroradiol 23:706–710PubMedGoogle Scholar
  47. 47.
    Masuo O, Terada T, Walker G, Tsuura M, Nakai K, Itakura T (2005) Patency of perforating arteries after stent placement? A study using and in vivo experimental atherosclerosis-induced model. Am J Neuroradiol 26:543–548PubMedGoogle Scholar
  48. 48.
    Levy EI, Boulos AS, Hanel RA, Tio FO, Alberico RA, Fronckowiak MD, Nemes B, Paciorek AM, Guterman LR, Hopkins NH (2003) In vivo model of intracranial stent implantation: a pilot study to examine the histological response of cerebral vessels after randomized implantation of heparin-coated and uncoated endoluminal stents in a blinded fashion. J Neurosurg 98:544–553CrossRefPubMedGoogle Scholar
  49. 49.
    Tanaka S, Watanabe S, Matsuo H, Segawa T, Iwama M, Hirose T, Takahashi H, Ono K, Warita S, Kojima T, Minatoguchi S, Fujiwara H (2008) Prospective randomized trial comparing a nitinol self-expanding coronary stent with low-pressure dilatation and a high-pressure balloon expandable bare metal stent. Heart Vessels 23:1–8CrossRefPubMedGoogle Scholar
  50. 50.
    Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT (2006) Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 66:1868–1872CrossRefPubMedGoogle Scholar
  51. 51.
    Alibadi D, Tilli FV, Bowers TR, Benzuly KH, Safian RD, Goldstein JA, Grines CL, O’Neill WW (1997) Am J Coll Cardiol 80:994–997Google Scholar
  52. 52.
    Cho GY, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ (2001) Effects of stent design on side branch occlusion after coronary stent placement. Catheter Cardiovasc Interv 52(1):18–23CrossRefPubMedGoogle Scholar
  53. 53.
    Riedel CH, Tietke M, Alfke K, Stingele R, Jansen O (2009) Subacute stent thrombosis in intracranial stenting. Stroke 40:1310–1314CrossRefPubMedGoogle Scholar
  54. 54.
    Jiang WJ, Du B, Leung TW, Xu XT, Jin M, Dong KH (2007) Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Radiology 243:188–197CrossRefPubMedGoogle Scholar
  55. 55.
    van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, Kolen JJ, Brueren BR, Dambrink JHE, Hautvast RW, Verheugt FW, ten Berg JM (2009) Predictors of coronary stent thrombosis—the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 53:1399–1409CrossRefPubMedGoogle Scholar
  56. 56.
    Prabhrakan S, Wells KR, Lee VH, Flaherty CA, Lopes DK (2007) Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. Am J Neuroradiol 29:281–285CrossRefGoogle Scholar
  57. 57.
    Brandt JT, Payne CD, Wiviott SD, Weerakkody G, Farid NA, Small DS, Jakubowski JA, Naganuma H, Winters KJ (2007) A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 153:66.e9–66.e16CrossRefGoogle Scholar
  58. 58.
    Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman M, for the TRITON-TIMI 38 investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndrome. N Engl J Med 357:2001–2015CrossRefPubMedGoogle Scholar
  59. 59.
    The SSYLVIA Study Investigators (2004) Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA). Stroke 35:1388–1392CrossRefGoogle Scholar
  60. 60.
    Miao ZR, Feng L, Li S, Zhu F, Ji X, Jiao L, Ling F (2009) Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow up at a single center. Neurosurgery 64:79–85CrossRefPubMedGoogle Scholar
  61. 61.
    Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Lynn MJ, Chimowitz M, For the NIH Multicenter Wingspan Intracranial Stent Registry Study Group (2008) The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 70:1518–1524CrossRefPubMedGoogle Scholar
  62. 62.
    Mazighi M, Yadav JS, Abou-Chebl A (2008) Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 39:1766–1769CrossRefPubMedGoogle Scholar
  63. 63.
    Fiorella D, Chow M, Anderson M, Woo H, Rasmussen PA, Masaryk TJ (2007) A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar atheromatous disease. Neurosurgery 61:236–243CrossRefPubMedGoogle Scholar
  64. 64.
    Bose A, Hartmann M, Henkes H, Liu HM, Teng M, Szikora I, Berlis A, Reul J, Yu S, Forsting M, Lui M, Lim W, Po Sit S (2007) A novel self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses The Wingspan Study. Stroke 38:1531–1537CrossRefPubMedGoogle Scholar
  65. 65.
    Jiang WJ, Xu XT, Jin M, Du B, Dong KH, Dai JP (2007) Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. Am J Neuroradiol 28:830–834PubMedGoogle Scholar
  66. 66.
    Vajda Z, Miloslavski E, Güthe T, Schmid E, Schul C, Albes G, Henkes H (2009) Treatment of intracranial ahterosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue). Neuroradiology. doi:10.1007/s00234-009-0615-7 PubMedGoogle Scholar
  67. 67.
    Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella D (2007) Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation and management. Neurosurgery 61:644–651CrossRefPubMedGoogle Scholar
  68. 68.
    Turk AS, Levy EI, Albuquerque FC, Pride GL, Woo H, Welch BG, Niemann DB, Purdy PD, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella D (2008) Influence of patient age and stenosis location on wingspan in-stent restenosis. Am J Neuroradiol 29:23–27CrossRefPubMedGoogle Scholar
  69. 69.
    Fiorella D, Levy EI, Turk AS, Albuquerque FC, Pride GL, Woo hH, Welch BG, Niemann DB, Purdy PD, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG (2009) Target lesion revascularization after wingspan—assessment of safety and durability. Stroke 40:106–110CrossRefPubMedGoogle Scholar
  70. 70.
    Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG (2006) Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 37:2562–2566CrossRefPubMedGoogle Scholar
  71. 71.
    Steinfort B, Ng PP, Faulder K, Harrington T, Grinnel V, Sorby W, Morgan M (2007) Midterm outcomes of paclictaxel-eluting stents for the treatment of intracranial posterior circulation stenoses. J Neurosurg 106:222–225CrossRefPubMedGoogle Scholar
  72. 72.
    Boulos AS, Agner C, Deshaies EM (2005) Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res 27:S95–S102CrossRefPubMedGoogle Scholar
  73. 73.
    Abou-Chebl A, Bashir Q, Yadav JS (2005) Drug-eluting stents for treatment of intracranial atherosclerosis. Stroke 36:e165–e168CrossRefPubMedGoogle Scholar
  74. 74.
    Tamhane U, Meier P, Chetcuti S, Chen KY, Rha SW, Grossmann MP, Gurm H (2009) Efficacy of cilostazol in reducing restenosis in patients untergoing contemporary stent based PCI: a meta-analysis of randomized controlled trials. Euro Intervent 5:384–393Google Scholar
  75. 75.
    Biondi-Zoccai GG, Lotrionte M, Anselmino M, Moretti C, Agostoni P, Testa L, Abbate A, Cosgrave J, Laudito A, Trevi GP, Sheiban I (2008) Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention. Am Heart J 155:1081–1089CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Wiebke Kurre
    • 1
  • René Chapot
    • 1
  • Richard du Mesnil de Rochemont
    • 2
  • Joachim Berkefeld
    • 2
  1. 1.Department of NeuroradiologyAlfried-Krupp-KrankenhausEssenGermany
  2. 2.Department of NeuroradiologyGoethe UniversitätFrankfurtGermany

Personalised recommendations